# Alnylam Pharmaceuticals, Inc. – FDA Inspection, Apr 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/416acd03-3f7b-46f1-a91a-64c29ee36158
Source feed: FDA_Inspections

> FDA inspection 1050979 of Alnylam Pharmaceuticals, Inc., April 25, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050979
- Company Name: Alnylam Pharmaceuticals, Inc.
- Inspection Date: 2018-04-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1181120 - 2022-09-09
- FDA Inspection 1107254 - 2019-09-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/victoria-m-daddeo/f1832c5e-d242-4e1a-8c30-4c951c3976ea)

Company: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
